CVS HEALTH Corp — Director's Dealing 2012

Jun 22, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CVS CAREMARK CORP (CVS)
CIK: 0000064803
Period of Report: 2012-06-21

Reporting Person: Foulkes Helena (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-06-21	Common Stock	S	5749	$46.03	Disposed	8763.077	Direct
2012-06-21	Common Stock	M	23438	$34.42	Acquired	32201.077	Direct
2012-06-21	Common Stock	M	64237	$28.10	Acquired	96438.077	Direct
2012-06-21	Common Stock	S	23438	$45.9704	Disposed	73000.077	Direct
2012-06-21	Common Stock	S	64237	$45.9704	Disposed	8763.077	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-06-21	Stock Option	$34.42	M	23438	Disposed	2014-04-02	Common Stock (23438)	Direct
2012-06-21	Stock Option	$28.10	M	64237	Disposed	2016-04-01	Common Stock (64237)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock (pep)	4352.2477	Direct
Common Stock (restricted)	30358	Direct
ESOP Common Stock	3824.1204	Indirect
Stock Unit	9502.2082	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option	$41.17	2015-04-01	Common Stock (47568)	47568	Direct
Stock Option	$36.23	2017-04-01	Common Stock (53546)	53546	Direct
Stock Option	$34.96	2018-04-01	Common Stock (48230)	48230	Direct
Stock Option	$45.07	2019-04-02	Common Stock (39929)	39929	Direct
Stock Option	$34.96	2021-04-01	Common Stock (42910)	42910	Direct

Footnotes

F1: All sales were effected pursuant to a Rule 10b5-1 plan.

F2: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $45.88 and $46.23 per share.

F3: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $45.87 and $46.23 per share.

F4: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $45.87 and $46.23 per share.

F5: Option became exercisable in three equal annual installments, commencing 4/2/2008.

F6: Option became exercisable in three equal annual installments, commencing 4/1/2010.

F7: Option became exercisable in three equal annual installments, commencing 4/1/2009.

F8: Option became exercisable in three equal annual installments, commencing 4/1/2011.

F9: Option became exercisable in four equal annual installments, commencing 4/1/2012.

F10: Option becomes exercisable in four equal annual installments, commencing 4/2/2013.

F11: Option becomes exercisable in three equal annual installments, commencing 4/1/2014.